Kong Chen, Yang Meifeng, Yue Ningning, Zhang Yuan, Tian Chengmei, Wei Daoru, Shi Ruiyue, Yao Jun, Wang Lisheng, Li Defeng
The Second Clinical Medical College, Jinan University; Shenzhen, Guangdong, People's Republic of China.
Department of Hematology, Yantian District People's Hospital, Shenzhen, Guangdong, People's Republic of China.
J Inflamm Res. 2024 Aug 14;17:5389-5413. doi: 10.2147/JIR.S470520. eCollection 2024.
The intestinal barrier maintained by various types of columnar epithelial cells, plays a crucial role in regulating the interactions between the intestinal contents (such as the intestinal microbiota), the immune system, and other components. Dysfunction of the intestinal mucosa is a significant pathophysiological mechanism and clinical manifestation of inflammatory bowel disease (IBD). However, current therapies for IBD primarily focus on suppressing inflammation, and no disease-modifying treatments specifically target the epithelial barrier. Given the side effects associated with chronic immunotherapy, effective alternative therapies that promote mucosal healing are highly attractive. In this review, we examined the function of intestinal epithelial barrier function and the mechanisms of behind its disruption in IBD. We illustrated the complex process of intestinal mucosal healing and proposed therapeutic approaches to promote mucosal healing strategies in IBD. These included the application of stem cell transplantation and organ-like tissue engineering approaches to generate new intestinal tissue. Finally, we discussed potential strategies to restore the function of the intestinal barrier as a treatment for IBD.
由各种类型的柱状上皮细胞维持的肠道屏障,在调节肠道内容物(如肠道微生物群)、免疫系统和其他成分之间的相互作用中起着关键作用。肠黏膜功能障碍是炎症性肠病(IBD)的重要病理生理机制和临床表现。然而,目前IBD的治疗主要集中在抑制炎症,尚无针对上皮屏障的疾病改善治疗方法。鉴于慢性免疫治疗的副作用,促进黏膜愈合的有效替代疗法极具吸引力。在本综述中,我们研究了肠道上皮屏障功能及其在IBD中破坏的机制。我们阐述了肠黏膜愈合的复杂过程,并提出了促进IBD黏膜愈合策略的治疗方法。这些方法包括应用干细胞移植和类器官组织工程方法来生成新的肠道组织。最后,我们讨论了恢复肠道屏障功能作为IBD治疗方法的潜在策略。